Myriad Genetics Inc (MYGN) 20.75 $MYGN Services Stocks

New Post Public Reply Private Reply Replies (0) Message Board

Sep 22, 2016 at 5:03 AM

Myriad Genetics Inc (MYGN) 20.75 $MYGN

Services Stocks on Investors' Radar -- HERC, Myriad Genetics, Qiagen, and INC Research
PR Newswire - Wed Sep 21, 6:30AM CDT
Today, Stock-Callers reviews the performance of these services stocks: HERC Holdings Inc. (NYSE: HRI), Myriad Genetics Inc. (NASDAQ: MYGN), Qiagen NV (NASDAQ: QGEN), and INC Research Holdings Inc. (NASDAQ: INCR). At the close of Tuesday's trading session, the NASDAQ Composite ended the trading session at 5,241.35, up 0.12%; the Dow Jones Industrial Average edged 0.05% higher, to finish at 18,129.96; and the S&P 500 closed at 2,139.76, up 0.03%. Learn more about these stocks by accessing their free research reports at:
MYGN: 20.75 (-0.01), INCR: 43.88 (+0.72), HRI: 32.91 (+0.29), QGEN: 26.45 (+0.26)

Shares of MYGN Down 39.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Sep 19, 1:05PM CDT
SmarTrend identified a Downtrend for Myriad Genetics (NASDAQ:MYGN) on May 4th, 2016 at $34.70. In approximately 5 months, Myriad Genetics has returned 39.05% as of today's recent price of $21.15.
MYGN: 20.75 (-0.01)

SmarTrend Watching for Potential Pullback in Shares of Myriad Genetics After 4.06% Gain
Comtex SmarTrend(R) - Wed Sep 14, 3:25PM CDT
Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $20.82 to a high of $21.82. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $21.03 on volume of 758,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYGN: 20.75 (-0.01)

Myriad Genetics Rises 4.06% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Sep 14, 3:24PM CDT
Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $20.82 to a high of $21.82. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $21.03 on volume of 758,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYGN: 20.75 (-0.01)

Myriad Genetics' TruCulture Study Results Favorable
Zacks Equity Research - Zacks Investment Research - Mon Sep 12, 8:28AM CDT
Myriad RBM, a part of Myriad Genetics (MYGN) recently announced the release of positive data from Milieu Interieur Project which is based on its TruCulture platform.
MYGN: 20.75 (-0.01), GWPH: 107.96 (-0.33), QDEL: 21.88 (-1.03), NUVA: 67.00 (+0.11)

Shares of MYGN Down 40.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Sep 09, 1:06PM CDT
SmarTrend identified a Downtrend for Myriad Genetics (NASDAQ:MYGN) on May 4th, 2016 at $34.70. In approximately 4 months, Myriad Genetics has returned 40.84% as of today's recent price of $20.53.
MYGN: 20.75 (-0.01)

Myriad RBM's TruCulture(R) and Gene Expression Profiling Characterizes Immune Responses in Landmark Study Led by Institut Pasteur
GlobeNewswire - Wed Sep 07, 6:05AM CDT
Myriad RBM, Inc., a wholly owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN) a global leader in personalized medicine, announced today that researchers from the Institut Pasteur have published new landmark research from the Milieu Interieur Project relating to the ability to perform standardized transcriptome profiling based upon a variety of immune stimuli in the August issue of Cell Reports. The study looked at the expression levels of different genes in 25 subjects following TruCulture incubation with twenty clinically relevant immune system stimulants. The research demonstrated that expression levels from as few as 44 of the 572 genes tested could segregate responses from the various stimuli and reveal variations in immune response.
MYGN: 20.75 (-0.01)

Myriad Genetics Adds Assurex Health, Grows in Neuroscience
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 3:36PM CDT
Myriad Genetics, Inc. (MYGN) recently closed its earlier announced acquisition of Assurex Health.
MYGN: 20.75 (-0.01), HSKA: 54.50 (-1.18), ANIP: 65.12 (+0.28), ANIK: 47.93 (+0.34)

Downtrend Call Working As Myriad Genetics Stock Falls 41.1% (MYGN)
Comtex SmarTrend(R) - Fri Sep 02, 12:52AM CDT
SmarTrend identified a Downtrend for Myriad Genetics (NASDAQ:MYGN) on May 4th, 2016 at $34.70. In approximately 4 months, Myriad Genetics has returned 41.10% as of today's recent price of $20.44.
MYGN: 20.75 (-0.01)

Myriad Genetics Completes Acquisition of Assurex Health
GlobeNewswire - Thu Sep 01, 3:05PM CDT
Myriad Genetics, Inc. (NASDAQ:MYGN) a global leader in personalized medicine, announced today that it has completed its acquisition of Assurex Health effective August 31, 2016. Assurex Health, which is based in Mason, Ohio, is an informatics-based precision medicine company providing treatment decision support to healthcare providers for mental health patients.
MYGN: 20.75 (-0.01)

Myriad Genetics to Present at the 2016 Morgan Stanley Global Healthcare Conference
GlobeNewswire - Tue Aug 30, 3:05PM CDT
Myriad Genetics, Inc. (NASDAQ:MYGN) announced today that Mark C. Capone, president and CEO, Myriad Genetics, is scheduled to present at the 2016 Morgan Stanley Global Healthcare Conference at 9:20 a.m. ET on September 12, 2016, at the Grand Hyatt New York in New York City.
MYGN: 20.75 (-0.01), MS: 31.92 (+0.22)

Medical Device Leader Series: Top Companion Diagnostics (CDx) Developers, Manufacturers and Marketers in 2016
PR Newswire Europe - Wed Aug 24, 8:02AM CDT
LONDON, August 24, 2016 /PRNewswire/ --
JNJ: 118.91 (+0.96), ABT: 41.92 (+0.34), MYGN: 20.75 (-0.01), A: 46.04 (+0.33)

Weakness Seen in Myriad Genetics (MYGN) Estimates: Should You Stay Away?
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 6:59AM CDT
Myriad Genetics (MYGN) should not be considered as it holds an unfavorable Zacks Rank and it has seen negative earnings estimate revisions.
MYGN: 20.75 (-0.01), CBM: 46.77 (+0.78)

Myriad Genetics: Q4 Hit by Low Test Revenues, Gross Margin
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 7:38AM CDT
Myriad (MYGN) ended fiscal 2016 on a disappointing note, with its fourth-quarter numbers missing the Zacks Consensus Estimate on both fronts.
MYGN: 20.75 (-0.01), HSKA: 54.50 (-1.18), ANIP: 65.12 (+0.28), ANIK: 47.93 (+0.34)

Myriad Genetics (MYGN) in Focus: Stock Up 5.6% in Session
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 7:35AM CDT
Myriad Genetics, Inc. (MYGN) was a big mover last session, as the company saw its shares rise around 6% on the day.
MYGN: 20.75 (-0.01), ANIP: 65.12 (+0.28)

Downgrade Alert for Myriad Genetics (MYGN)
Comtex SmarTrend(R) - Thu Aug 11, 3:54AM CDT
Myriad Genetics (NASDAQ:MYGN) was downgraded from Buy to Hold at Gabelli & Co today. The stock closed yesterday at $19.70 on volume of 19.0 million shares, above average daily volume of 853,000. Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.
MYGN: 20.75 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Saga Metals Advances Radar Project with HQ Drill Success

Digging Deep at Trapper North: Saga's Strategic Drill Move There's nothing like the thrill of discovery, especially in the rough-and-tumble world of mining exploration. Saga Metals Corp., anchored deep in the critical minerals scene, has wrapped up an HQ-diameter drill program at its Radar Project, smack dab near Cartwright, Labrador. You hear 1,010 meters and maybe...

Vehicle Reliability Hinges on Design and Maintenance

Why Some Cars Age Like Fine Wine—and Some Don't Here’s the thing—cars aren’t all made equal, and anybody who's tinkered around under the hood for a few years long knows that some vehicles just can’t hold it together as time marches on. Now, this ain't rocket science, but the truth is wrapped up in the complexity of designs and those pesky little maintenance...

TagniFi Spread: AI Transforming Financial Analysis

Ah, finance folks, we've all been there—lost in the trenches, teeth gritted as we manually grind through private company financials. It's like trying to piece together a 1,000-piece jigsaw puzzle without a picture of the final scene. But now, someone's come along and flipped on the light switch. Enter TagniFi Spread, the new AI-powered tool that's snapped a whole lot of...

AI Governance Market to Hit $12.5B by 2030

AI Governance: The Enforcer's Playground Well, with every Tom, Dick, and Harry out there tinkering with artificial intelligence, it's no shocker we've come to this. Peeled back, the AI governance platforms market's pegged to hit a whopping $12.5 billion by 2030. The AIMG's report spells this out with the kind of clarity even an intern could appreciate. But here's the rub:...

TSX Surges Amid Earnings Wave and Market Momentum

TSX Soars, But What's Driving the Surge? Gotta say, when the TSX leaps over 2% in a single day, it sets the stage for two things: excitement and scrutiny. On a balmy Wednesday, Canada's stock market stood tall at 36,317.67, up 785.39 points. Wall Street joined the dance too, with the Dow kicking up by 1,543.75 points. Good vibes all around — but hang on a minute. You...

DraftKings Faces Scrutiny Over AI Use in Promotions

DraftKings Under the Legal Microscope So here's a doozy that’s rattling through Beantown: DraftKings, the sportsbook titan, might be walking on financial eggshells thanks to their bold use of artificial intelligence. Shapiro Haber & Urmy, a doughty Boston legal jockey, is giving the high sign to users about a consumer class action investigation involving DraftKings'...

Pearson-Westermann Partnership Boosts English Skills in Germany

Revolutionizing English Education in Germany Alright, folks, here's the scoop for all you with a toe in education and workforce development. Pearson and Westermann are shaking hands to tackle one of the biggest skills needed in Germany: English proficiency. This might sound like a dry move on the surface, but trust me, it's a game-changer for students and job seekers...

Cincoro Tequila Unveils Rare Añejo for Holidays

Firing Up the Holiday Spirit with Cincoro Well, isn't this a timely toast to class? As if the tequila scene wasn't already brimming with options, Cincoro's decided to paint the town gold with a rare addition to its lineup. For those of you who treat your liquor collection like a stockpile of fine art, here's something that'll turn heads this holiday season—the Añejo...

Texans Credit Union Ranks High in Workplace Satisfaction

Building a Culture of Value and Growth Try saying no to recognition when you prioritize your people, and Texans Credit Union knows it well. Their consistent Top Workplace ranking—four years running, mind you—speaks volumes about a company truly valuing its workforce. Landing at No. 6 among midsize companies in The Dallas Morning News' 2026 D-FW list, they’re...

Everest Group Faces Shaky Ground in Securities Fraud Suit

Investors Take Aim at Everest Group's Alleged Missteps Looks like Everest Group, Ltd. (NYSE: EG) has found itself knee-deep in legal quicksand. There's a class-action lawsuit afoot, spearheaded by the folks at Schall, Brown & Schwartz LLP. They're putting forward claims that Everest, a player in the securities exchange, was painting a misleading picture when it came to...